Qiagen names new CEO
Jonathan Pratt will take over the role on Sept. 1. The announcement ends Qiagen’s nearly 10-month search for a new chief executive.
Uncategorized
Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten rebound
Twenty-five biotechs have used the IPO route to go public this year—with five of those debuts occurring this month alone. It’s the most IPOs since 2021, when the industry recorded 78 during the height of the COVID-19 pandemic.
Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten rebound Read More »
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test Read More »
VA deploys Oracle EHR to 3 medical centers in Indiana
The Department of Veterans Affairs is making progress on its goal to add the new electronic health record to all of its medical centers. Past deployments have been plagued by technical challenges and delays.
VA deploys Oracle EHR to 3 medical centers in Indiana Read More »
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
Haisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more. The new company will take on one of Haisco’s core immunology assets.
China’s Haisco forms immunology biotech with up to $1.5B from American VCs Read More »
Lilly takes oral obesity race abroad with UK launch of Foundayo
Eli Lilly’s best play for Foundayo is to bring it overseas, a more price-sensitive market where the pharma can more readily outcompete Novo Nordisk “given the high margins of a small-molecule therapy,” Truist analyst Srikripa Devarakonda told BioSpace.
Lilly takes oral obesity race abroad with UK launch of Foundayo Read More »
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
While Bausch + Lomb’s dual-action eye drops failed to outperform active comparators at day 29, the investigational asset showed significant superiority at day 15.
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail Read More »
El lápiz que escribe sin mina ni tinta funciona oxidando el papel
Hay un objeto de escritorio que desconcierta a quien lo prueba por primera vez. Parece un lápiz, se coge como un lápiz y deja un trazo gris parecido al del grafito, pero no tiene mina de madera ni cartucho de tinta. Es el llamado lápiz infinito, y su gracia está en que no …
El lápiz que escribe sin mina ni tinta funciona oxidando el papel Read More »
Kurt Lewin: El visionario que revolucionó la psicología social y cambió cómo entendemos los grupos
Si alguna vez has trabajado en equipo, escuchado hablar del «liderazgo dinámico» o participado en un taller de desarrollo personal, le debes más de lo que crees a Kurt Lewin. Considerado de forma unánime como el padre de la psicología social moderna, este psic …
Relojes inteligentes: la tecnología de salud que ya no cuesta una fortuna
El reloj inteligente ha pasado de ser un accesorio caro a un dispositivo de salud accesible. Medir el sueño, la frecuencia cardíaca, el oxígeno en sangre o los pasos del día era, hace no tanto, terreno de modelos premium. Hoy esas funciones han bajado a la gama …
Relojes inteligentes: la tecnología de salud que ya no cuesta una fortuna Read More »